Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,594 | -20,145 | -18,746 | -14,541 | -9,766 |
| Depreciation Amortization | N/A | 79 | 362 | 430 | 1,320 |
| Income taxes - deferred | 197 | N/A | N/A | N/A | -180 |
| Accounts receivable | N/A | 229 | -1,028 | -29 | -142 |
| Other Working Capital | -511 | 1,996 | 14,900 | 1,271 | 874 |
| Other Operating Activity | 2,573 | 4,342 | 4,432 | 3,897 | 2,517 |
| Operating Cash Flow | $-12,335 | $-13,499 | $-80 | $-8,973 | $-5,376 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,642 | N/A | N/A | N/A | N/A |
| PPE Investments | -7 | -7 | N/A | N/A | -120 |
| Net Acquisitions | 241 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 27,460 | -16,124 | -200 | 74 | -76 |
| Investing Cash Flow | $-8,947 | $-16,132 | $-200 | $74 | $-196 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -2 | N/A | 3 | -984 |
| Debt Issued | N/A | N/A | -119 | N/A | 1,498 |
| Debt Repayment | 120 | N/A | -1,705 | N/A | N/A |
| Common Stock Issued | N/A | 102 | 56,224 | 9,867 | 7,436 |
| Other Financing Activity | -60 | -121 | -4,257 | -847 | -644 |
| Financing Cash Flow | $61 | $-21 | $50,143 | $9,024 | $7,305 |
| Exchange Rate Effect | N/A | N/A | N/A | 17 | -5 |
| Beginning Cash Position | 26,332 | 57,420 | 4,685 | 4,506 | 2,839 |
| End Cash Position | 5,110 | 27,769 | 54,548 | 4,648 | 4,567 |
| Net Cash Flow | $-21,221 | $-29,651 | $49,863 | $142 | $1,728 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,335 | -13,499 | -80 | -8,973 | -5,376 |
| Capital Expenditure | -7 | -7 | N/A | N/A | -120 |
| Free Cash Flow | -12,342 | -13,506 | -80 | -8,973 | -5,496 |